Second Line Capital, LLC Merck & Co., Inc. Transaction History
Second Line Capital, LLC
- $371 Billion
- Q4 2024
A detailed history of Second Line Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Second Line Capital, LLC holds 5,066 shares of MRK stock, worth $467,338. This represents 0.14% of its overall portfolio holdings.
Number of Shares
5,066
Previous 5,337
5.08%
Holding current value
$467,338
Previous $610 Million
16.72%
% of portfolio
0.14%
Previous 0.17%
Shares
5 transactions
Others Institutions Holding MRK
# of Institutions
3,965Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.2 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.2 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.45 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.64 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $234B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...